Here's What Key Metrics Tell Us About NeoGenomics (NEO) Q2 EarningsZacks Investment Research • 07/29/24
Fort Myers' Mayor to Proclaim June as NeoGenomics' Commitment to Cancer MonthBusiness Wire • 06/13/24
Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global MarketingGlobeNewsWire • 06/10/24
NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment ManagementBusiness Wire • 05/28/24
Here's What Key Metrics Tell Us About NeoGenomics (NEO) Q1 EarningsZacks Investment Research • 04/30/24
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual MeetingBusiness Wire • 03/27/24
All You Need to Know About NeoGenomics (NEO) Rating Upgrade to BuyZacks Investment Research • 03/20/24
Does NeoGenomics (NEO) Have the Potential to Rally 43.34% as Wall Street Analysts Expect?Zacks Investment Research • 03/20/24
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) ReportBusiness Wire • 03/20/24
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care ConferenceBusiness Wire • 03/01/24
Wall Street Analysts Predict a 29.57% Upside in NeoGenomics (NEO): Here's What You Should KnowZacks Investment Research • 02/28/24
NeoGenomics (NEO) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 02/21/24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEOPRNewsWire • 01/31/24